Psychedelics May Help Solve Addiction

Solvable

Pushkin Industries

Society & Culture, News

4.4 • 602 Ratings

🗓️ 6 October 2021

⏱️ 21 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Matthew Johnson is a Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University where research is underway to explore the therapeutic potential of psychedelic drugs to break through the crushing impact of addiction and other mental health disorders.

Here are some of the resources Johnson mentions in this episode:

Johns Hopkins University’s Center for Psychedelic and Consciousness Research

https://hopkinspsychedelic.org/

National Institutes of Health Clinical Trials

https://clinicaltrials.gov/

Multidisciplinary Association for Psychedelic Studies (MAPS)

https://maps.org/

Solvable is produced by Jocelyn Frank, research by David Zha, booking by Lisa Dunn, managing producer is Sachar Mathias and the executive producer is Mia Lobel.

Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

See omnystudio.com/listener for privacy information.

Transcript

Click on a timestamp to play from that location

0:00.0	This is an I-Heart podcast.
0:14.8	This is Solvable. I'm Ronald Young Jr.
0:19.6	The major focus is in leveraging them as therapeutics.
0:24.7	In other words, to treat various disorders, mainly psychiatric disorders,
0:29.0	like various forms of addiction, like depression, like helping cancer and other serious illness patients.
0:38.5	According to the National Institutes of Health,
0:41.3	mental health disorders account for several of the top causes of disability
0:44.6	across the United States.
0:46.8	About six out of every 100 people will have PTSD at some point in their lives.
0:51.5	That's about 15 million adults during a given year.
0:55.0	Over one quarter of all Americans, over 18,
0:58.5	suffer from a diagnosable mental illness.
1:01.7	The antidepressants we have now are somewhat safer
1:05.5	than the ones going back to the 1950s,
1:07.9	but they work on the same basic mechanisms
1:10.5	of taking a drug daily and
1:13.2	it augmenting the amount of serotonin. Matthew Johnson is a professor of psychiatry and behavioral
1:19.2	sciences at Johns Hopkins University. With so many suffering, he thinks it's urgent to expand the tools
1:26.0	we use for treatment. The potential approval of psychedelic drugs, this could happen in a few years, and I think this has the potential to really be a paradigm shift in mental health treatment.
1:38.3	Psychedelics are reality-altering drugs, with names like Mali, Ecstasy,, Mescaline, LSD, psilocybin.
1:47.3	And they're all classified as Schedule I drugs, government defined as having no accepted medical
1:52.8	use and a high potential for abuse.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Pushkin Industries, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Pushkin Industries and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.